No Picture
News

CORRECTION – Pacific Biosciences of California, Inc. Fourth Quarter 2019 Financial Results Call

MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Pacific Biosciences of California, Inc. (NASDAQ: PACB), please note that the date in paragraph three should read February 6, 2020, not … […]

No Picture
News

Pacific Biosciences of California, Inc. Fourth Quarter 2019 Financial Results Call

MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Fourth Quarter 2019 Financial Results on Thursday, February 6, 2020, at 4:30pm Eastern… […]

No Picture
News

OptraHEALTH Collaborates with Microsoft Azure to Serve Genomic Health Industry with the Launch of “GeneFAX™ Pro”

SAN JOSE, Calif.–(BUSINESS WIRE)– #Genomics–OptraHEALTH today announced collaboration with Microsoft Azure for availability of their AI based platform for Genomics – GeneFAX Pro. […]

No Picture
News

Science Exchange Joins Accenture’s INTIENT Network for Research to Help Boost R&D Productivity in Drug Discovery and Development

PALO ALTO, Calif.–(BUSINESS WIRE)–Science Exchange, the SaaS-enabled marketplace for outsourced R&D, joins Accenture’s INTIENT Network for Research. […]

No Picture
News

Horizon Discovery Grants a Multi-Product Use License of its GS knockout CHO K1 Cell Line to NGM Bio

CAMBRIDGE, England–(BUSINESS WIRE)–Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will licens… […]

No Picture
News

Seattle Genetics Achieves Milestone Following European Commission Approval of Roche’s Polivy® (Polatuzumab Vedotin)

BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it will receive a milestone payment from Roche triggered by European Commission conditional marketing authorisation for Polivy® (polatuzumab vedotin). Polivy is … […]